A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats
ConclusionThe EN + RAL treatment appeared to be promising in preventing male osteoporosis, but given the observed side effects on liver, kidney, and prostate weights, it requires further investigation.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Diets | Endocrinology | Evista | Genetics | Liver | Nutrition | Orthopaedics | Osteoporosis | Study | Urology & Nephrology